You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIM4CML,

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eustachian Tube Dysfunction Trial in Pittsburgh (ET Stress test, Sonotubometry, Forced Response Test (FRT))

Terminated
  • Eustachian Tube Dysfunction
  • ET Stress test
  • +8 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Middle Ear Physiology Laboratory
Oct 6, 2020

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting
  • GIST and CML
  • imatinib mesylate
  • Los Angeles, California
  • +28 more
Apr 25, 2022

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Chronic Subdural Hematoma Trial in Calgary (Dexamethasone, Any surgical intervention aim at treating chronic subdural hematoma)

Unknown status
  • Chronic Subdural Hematoma
  • Dexamethasone
  • Any surgical intervention aim at treating chronic subdural hematoma
  • Calgary, Alberta, Canada
    University of Calgary
Jun 29, 2020

Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Patient-Derived Tumor Organoids
  • Hong Kong, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Oct 12, 2023

Microbial Colonization, Burns Trial

Recruiting
  • Microbial Colonization
  • Burns
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 31, 2023

    Diabetes Type 1 Trial in Australia (GNbAC1, Placebo)

    Completed
    • Diabetes Mellitus Type 1
    • Macquarie University, New South Wales, Australia
    • +12 more
    Oct 19, 2020

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Fayetteville, Arkansas
    • +22 more
    Jun 29, 2021

    Prostate Cancer, Prostate Cancer, Familial, Hereditary Prostate Cancer Trial (Genetic Risk Score: Number Format, Genetic Risk

    Completed
    Has Results
    • Prostate Cancer
    • +2 more
    • Genetic Risk Score: Number Format
    • +3 more
    • (no location specified)
    Nov 4, 2019

    Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ambiguous Lineage Leukemia or Lymphoma Trial in Washington, Atlanta,

    Not yet recruiting
    • Acute Lymphocytic Leukemia
    • +3 more
    • Washington, District of Columbia
    • +2 more
    Feb 21, 2022

    Leukemia Trial in Canada, United States (troxacitabine)

    Completed
    • Leukemia
    • Duarte, California
    • +19 more
    Jun 7, 2021

    Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

    Not yet recruiting
    • Obesity
    • Cardiovascular Diseases
    • Phoenix, Arizona
    • +165 more
    May 22, 2023

    OCD Trial in Worldwide (Troriluzole, Placebo)

    Recruiting
    • Obsessive-Compulsive Disorder
    • Phoenix, Arizona
    • +108 more
    Aug 18, 2022

    Metabolic Alternation and Clinicohematological Characteristic in

    Not yet recruiting
    • CML, Chronic Phase
    • Tyrosine kinase inhibitor
    • (no location specified)
    Nov 6, 2023

    3rd Line Therapy or More to Treat Adult CML- CP in Real World

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Oct 16, 2023

    Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

    Recruiting
    • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
    • Longmont, Colorado
    • +128 more
    Aug 1, 2022

    Chronic Myeloid Leukemia (CML) Trial in France

    Recruiting
    • Chronic Myeloid Leukemia (CML)
      • Annecy, France
      • +11 more
      Jul 18, 2023

      Effect of Pharmacogenetics on Imatinib Plasma Level and Response

      Active, not recruiting
      • Chronic Myeloid Leukemia
      • PCR
      • HPLC-UV
      • Assiut, Egypt
        South Egypt Cancer Institute
      Aug 6, 2022

      Previously Treated PH + CML Trial in Worldwide (Bosutinib)

      Terminated
      Has Results
      • Previously Treated PH + CML
      • Los Angeles, California
      • +47 more
      Dec 2, 2021

      Incision, Surgical, Suture, Complication, Incisional Hernia Trial (Small bite suturing Technique, Standardised Large Bites

      Not yet recruiting
      • Incision, Surgical
      • +2 more
      • Small bite suturing Technique
      • Standardised Large Bites Technique
      • (no location specified)
      Oct 31, 2021

      Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

      Not yet recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +2 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Aug 31, 2023

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

      Recruiting
      • Chronic Myelogenous Leukemia
      • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
      • Asciminib single agent
      • +5 more
      • Ann Arbor, Michigan
      • +49 more
      Jan 26, 2023

      Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

      Recruiting
      • Leukemia, Chronic Myelogenous
      • Chongqing City, Chongqing, China
      • +23 more
      Jan 18, 2023

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • +3 more
      • Duarte, California
      • +100 more
      Jun 8, 2021